The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]
The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. Whether you are a believer in the high valuations or not, these stocks have consistently posted double digit gains for more than half a decade and enthralled investors with their resiliency. That makes biotechnology companies worthy of consideration for those that are seeking high […]
Gaming execs: Join 180 select leaders from King, Glu, Rovio, Unity, Facebook, and more to plan your path to global domination in 2015. GamesBeat Summit is invite-only — apply here. Ticket prices increase on April 3rd!
Today Robinhood is opening up its zero-commission stock trading iOS app to everyone.The company’s initial app launch was something of a limited release. Only a select number of people were able […]
When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]
There’s nothing better than getting a great value — and let’s face it, when the market tumbles, often great stocks get crushed too. That could end up being particularly true in biotech. Since 2013, the industry’s return has tripled the S&P 500’s return, and that may mean that with the market slipping lately, biotech’s leading names — including Celgene — […]
In January we noted that despite Janet Yellen’s “irrational exuberance” moment when, last summer, the Fed chair mentioned biotech as a sector where valuations looked “substantially stretched,” biotech stocks have continued their relentless ascent thanks in part to M&A deals worth 40 times sales and IPOs for pre-revenue companies.Now, with the sector still making new highs, the bubble chorus is […]
Transportation is a growing sector and one that has seen a strong performance as of late. As a matter of fact, iShares Transportation Average ETF under the ticker (IYT – ETF report) has soared almost 30% in the last 52 weeks.While this is certainly a strong performance, let’s narrow it down and focus on some of the most undervalued companies […]
Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]
Hepatitis C treatment has progressed by leaps and bounds in the past few years, and appears to be accelerating even more quickly now. Cure rates have increased, treatment times are plummeting, and side effects are falling away. Is now the time to jump into the biotechs researching new drugs?Industry Focus takes a look at Regulus Therapeutics and Achillion Pharmaceuticals […]
